Skip to main content

Table 1 Patient characteristics

From: Next-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutations

Patient characteristics

(%)

Age (years)

 Range

54–79

Gender

 Male

5 (33.3)

 Female

10 (76.7)

Smoking status

 Non-smoker

9 (60.0)

 Former Smoker

6 (40.0)

Stage

 IV

14 (93.4)

 rIVa

1 (6.6)

1st line

5 (33.3)

2nd line

7 (46.7)

3rd line

2 (13.4)

Subsequent therapy

1 (6.6)

  1. arIV recurrent stage IV